[ad_1]
EC President Ursula von der Leyen said the Commission “has decided to make the first COVID-19 vaccine available to European citizens. We have granted conditional permission [platinti] in the market. “
The EVA said a few hours earlier that the vaccine, developed by German biotech company BioNTech and US pharmaceutical giant Pfizer, meets EU quality and safety standards. It was previously predicted that Brussels would approve distribution of the vaccine two to three days after the EEA decision.
The vaccine will go on sale next Saturday and the first vaccines in the EU will start on December 27 and 29.
The European Medicines Agency (EMA) has previously given the green light to Biontech and Pfizer.
The EEA Expert Committee (CHMP) recommended that the vaccine be licensed on Monday.
The EU has obtained up to 300 million euros. Biontech and Pfizer vaccine doses. This year, both partners aim to produce up to 50 million. doses, up to 1.3 billion next year.
Studies have shown that the efficacy of this vaccine is 95%.
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
